Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 1/2 2Phase 3 1Phase 2 1

Status

Active not recruiting 5Completed 3Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Papillomavirus Infections 3Acquired Immunodeficiency Syndrome 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Cisplatin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Completed × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT04982614 2025-08-24

HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini

Columbia University

Phase 4 Completed
1,403 enrolled

Acquired Immunodeficiency Syndrome, Papillomavirus Infections

NCT01824537 2025-03-19

TRAP-HPV

McGill University

Phase 4 Completed
372 enrolled 12 charts

Papillomavirus Infections

NCT04459221 2022-03-02

PROM SSCOL

Centre Hospitalier Universitaire de la Réunion

Phase 4 Completed
355 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡